A61P 33/06
Antimalarials
A61P33/06 (Antimalarials) appears on 2,238 US grants and 3,480 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,238
- Published applications
- 3,480
- Assignees
- 1,385
- Inventors
- 6,408
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 11 | 0 |
| 1998 | 15 | 0 |
| 1999 | 22 | 0 |
| 2000 | 22 | 0 |
| 2001 | 42 | 15 |
| 2002 | 51 | 52 |
| 2003 | 62 | 127 |
| 2004 | 28 | 182 |
| 2005 | 49 | 160 |
| 2006 | 60 | 152 |
| 2007 | 64 | 158 |
| 2008 | 70 | 161 |
| 2009 | 84 | 215 |
| 2010 | 115 | 307 |
| 2011 | 111 | 238 |
| 2012 | 157 | 229 |
| 2013 | 168 | 153 |
| 2014 | 168 | 166 |
| 2015 | 139 | 154 |
| 2016 | 133 | 147 |
| 2017 | 125 | 124 |
| 2018 | 96 | 124 |
| 2019 | 83 | 128 |
| 2020 | 84 | 109 |
| 2021 | 73 | 88 |
| 2022 | 52 | 83 |
| 2023 | 47 | 72 |
| 2024 | 46 | 61 |
| 2025 | 38 | 48 |
| 2026 | 17 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reducing malaria transmission25 Aug 2026US 12,714,109 B2GlaxoSmithKline Intellectual Property Development Limited
- Bioactive substance exhibiting antimalarial activity, and use for same14 Jul 2026US 12,679,805 B2Riken
- Methods for production of platelets from pluripotent stem cells and compositions thereof16 Jun 2026US 12,653,840 B2Astellas Institute for Regenerative Medicine
- Antimalarial agents19 May 2026US 12,629,374 B2Merck Sharp & Dohme Corp.
- Regimens of tafenoquine for prevention of malaria in malaria-naive subjects5 May 2026US 12,616,689 B260 Degrees Pharmaceuticals LLC
- Crispr-cas genome engineering via a modular aav delivery system8 Oct 2026US 2026/0308630 A1The Regents of the University of California
- Entry-modulating agents and uses therefor3 Sep 2026US 2026/0256822 A1
- Compositions for delivery of liver stage antigens and related methods3 Sep 2026US 2026/0256898 A1BioNTech SE
- Oligonucleotides for Reduction of PD-L1 Expression20 Aug 2026US 2026/0242462 A1Hoffman-LaRoche Inc.
- Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects13 Aug 2026US 2026/0232651 A160 Degrees Pharmaceuticals LLC
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Process for preparing diaminophenothiazinium compounds687US 8,765,942 B2Provence Technologies · 2014
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Human monoclonal antibodies to programmed death ligand 1 (PD-L1)628US 7,943,743 B2Medarex, Inc. · 2011
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003